Your browser doesn't support javascript.
loading
Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.
Uemoto, S; Ozawa, K; Kaido, T; Mori, A; Fujimoto, Y.
Afiliación
  • Uemoto S; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
  • Ozawa K; Hepatic Disease Research Institute, Kyoto, Japan.
  • Kaido T; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
  • Mori A; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
  • Fujimoto Y; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
Clin Exp Immunol ; 184(1): 126-36, 2016 Apr.
Article en En | MEDLINE | ID: mdl-26560892

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Metilprednisolona / Linfocitos T Citotóxicos / Trasplante de Hígado / Tacrolimus / Rechazo de Injerto / Inmunosupresores / Ácido Micofenólico Tipo de estudio: Etiology_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Metilprednisolona / Linfocitos T Citotóxicos / Trasplante de Hígado / Tacrolimus / Rechazo de Injerto / Inmunosupresores / Ácido Micofenólico Tipo de estudio: Etiology_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2016 Tipo del documento: Article País de afiliación: Japón